New evidence to guide ectopic pregnancy diagnosis and management

PC Brady - Obstetrical & gynecological survey, 2017 - journals.lww.com
New Evidence to Guide Ectopic Pregnancy Diagnosis and Manage... : Obstetrical &
Gynecological Survey New Evidence to Guide Ectopic Pregnancy Diagnosis and Management …

[HTML][HTML] Methotrexate therapy for ectopic pregnancies: a tertiary center experience

O Ozyuncu, A Tanacan, SA Duru… - Revista Brasileira de …, 2018 - SciELO Brasil
Objective Our aim is to demonstrate the importance of methotrexate (MTX) therapy for the
treatment of ectopic pregnancy (EP). Methods This retrospective study consisted of 99 …

Use of methotrexate in gynecologic and obstetric practice: what the radiologist needs to know

MV Revzin, JS Pellerito, M Moshiri, DS Katz… - …, 2021 - pubs.rsna.org
Methotrexate (MTX) is the primary pharmaceutical agent that is used for management of
disorders arising from trophoblastic tissue. Its widespread international use is mostly …

Conservative treatment in non-tubal ectopic pregnancy and predictors of treatment failure

E Nedopekina, S Escura, T Cobo, SR Hansson… - European Journal of …, 2021 - Elsevier
Objectives To find possible predictive factors to predict the failure of conservative treatment
of non-tubal ectopic pregnancy. For that purpose, we assessed the rate of failure …

[HTML][HTML] 血清β-人绒毛膜促性腺激素对甲氨蝶呤单次注射治疗异位妊娠结局的预测作用

闻笔伟, 俞晓敏, 顾仲毅, 蔡圣芸, 古航 - 第二军医大学学报, 2021 - html.rhhz.net
目的评估血清β-人绒毛膜促性腺激素(β-hCG) 对甲氨蝶呤(MTX) 单次肌内注射治疗异位妊娠
疗效的预测价值. 方法回顾性分析2010 年1 月1 日至2018 年12 月31 日在海军军医大学(第二 …